Hillsdale Investment Management Inc. Buys New Shares in Agilent Technologies, Inc. $A

Hillsdale Investment Management Inc. bought a new stake in shares of Agilent Technologies, Inc. (NYSE:A) in the 4th quarter, HoldingsChannel reports. The firm bought 6,700 shares of the medical research company’s stock, valued at approximately $912,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the business. Flynn Zito Capital Management LLC lifted its stake in Agilent Technologies by 3.2% during the third quarter. Flynn Zito Capital Management LLC now owns 2,257 shares of the medical research company’s stock valued at $290,000 after purchasing an additional 69 shares during the last quarter. Gabelli Funds LLC lifted its stake in Agilent Technologies by 1.1% during the third quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock valued at $850,000 after buying an additional 74 shares in the last quarter. Fiduciary Trust Co lifted its stake in Agilent Technologies by 1.6% during the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after buying an additional 77 shares in the last quarter. NorthCrest Asset Manangement LLC lifted its stake in Agilent Technologies by 1.6% during the fourth quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock valued at $726,000 after buying an additional 79 shares in the last quarter. Finally, Freestone Capital Holdings LLC lifted its stake in Agilent Technologies by 2.0% during the fourth quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock valued at $574,000 after buying an additional 84 shares in the last quarter.

Agilent Technologies Trading Up 0.4%

NYSE:A opened at $136.08 on Tuesday. The stock’s 50 day moving average price is $116.42 and its 200 day moving average price is $128.54. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.27. The company has a market capitalization of $38.46 billion, a P/E ratio of 27.33, a P/E/G ratio of 2.77 and a beta of 1.26. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.84 billion for the quarter, compared to the consensus estimate of $1.80 billion. During the same quarter in the prior year, the company posted $1.31 earnings per share. The firm’s revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, research analysts forecast that Agilent Technologies, Inc. will post 5.98 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be issued a $0.255 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is currently 20.48%.

Wall Street Analysts Forecast Growth

A has been the subject of a number of analyst reports. Robert W. Baird upped their price objective on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research note on Tuesday, May 26th. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday. Royal Bank Of Canada initiated coverage on shares of Agilent Technologies in a research note on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price objective for the company. UBS Group reduced their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Finally, Bank of America raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and reduced their price objective for the company from $150.00 to $145.00 in a research note on Thursday, May 28th. Two analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $162.79.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.